SBFM
Sunshine Biopharma Inc (SBFM)
Healthcare • NASDAQ • $2.040.00%
- Symbol
- SBFM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $2.04
- Daily Change
- 0.00%
- Market Cap
- $4.52M
- Trailing P/E
- N/A
- Forward P/E
- 0.01
- 52W High
- $24.30
- 52W Low
- $2.01
- Analyst Target
- $56.00
- Dividend Yield
- N/A
- Beta
- N/A
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifung…
Company websiteResearch SBFM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.